QIAGEN OmicSoft and Biomedical Knowledge Base

QIAGEN Biomedical KB-HD: data- and analytics-driven drug discovery

287 views
May 14, 2024
Ingenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many more applications.

In this webinar, we will introduce Biomedical KB-HD and how it allows its users to tackle applications that are not feasible with the Ingenuity Pathway Analysis graphical user interface or can be done faster and with more flexibility programmatically. We will demonstrate queries such as

• Quickly find the shortest connections between genes/proteins/metabolites of interest in the context of specific disease through queries
• Systematically build a network given a short list of genes/proteins/metabolites/chemicals
• Recreate a drug mechanism of action

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...

1,981 views July 19, 2022

High-quality biomedical relationships knowledge is the cornerstone of modern...

QIAGEN OmicSoft and Biomedical Knowledge Base

Identify mutation hotspots in a gene of interest

728 views May 08, 2019

In several cancers, IDH1 is frequently mutated at arginine 132, which alters...

QIAGEN OmicSoft and Biomedical Knowledge Base

Transcriptomics, Proteomics and Metabolic Changes in Post-Natal Mouse Heart analyzed with...

653 views November 07, 2019

In the full talk, Jean-Noël Billaud, Ph.D. Senior Principal Scientist,...

QIAGEN OmicSoft and Biomedical Knowledge Base

Supercharge your AI in drug discovery with high-quality biomedical data

637 views October 11, 2023

If you’re working in pharma or biotech, you likely rely on artificial...